SCHEDULE 13D/A

RENEO PHARMACEUTICALS INC

Common Stock, par value $0.0001 per share · CUSIP: 75974E103

Event date: 2025-01-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• RiverVest Venture Fund III, L.P.Reported CIK 0001601559

  Shares: 25,400.00 · Class: 0.20%

• RiverVest Venture Fund III (Ohio), L.P.Reported CIK 0001636686

  Shares: 1,349.00 · Class: 0.01%

• RiverVest Venture Partners III (Ohio), LLCReported CIK 0001611644

  Shares: 1,349.00 · Class: 0.01%

• RiverVest Venture Partners III, L.P.Reported CIK 0001752268

  Shares: 26,749.00 · Class: 0.21%

• RiverVest Venture Partners III, LLCReported CIK 0001752405

  Shares: 26,749.00 · Class: 0.21%

• RiverVest Venture Fund IV, L.P.Reported CIK 0001725443

  Shares: 169,449.00 · Class: 1.34%

• RiverVest Venture Partners IV, L.P.

  Shares: 169,449.00 · Class: 1.34%

• RiverVest Venture Partners IV, LLC

  Shares: 169,449.00 · Class: 1.34%

• John P. McKearn, Ph.D.Reported CIK 0001240120

  Shares: 196,198.00 · Class: 1.55%

• Jay SchmelterReported CIK 0001435248

  Shares: 196,198.00 · Class: 1.55%

• Thomas C. MelzerReported CIK 0001611651

  Shares: 26,749.00 · Class: 0.21%

• Niall O'Donnell, Ph.D.Reported CIK 0001780235

  Shares: 169,449.00 · Class: 1.34%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.